# "Computer Crossmatch" (Computerized Analysis of the Compatibility between the Donor's Cell Type and the Recipient's Serum or Plasma Type); :  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/computer-crossmatch-computerized-analysis-of-the-compatibility-between-the-donors-cell-type-and-the-recipients-serum-or-plasma-type-guidance-for-industry/1a1fe388-f721-4c5e-ab85-ef8178139070

> FDA guidance document: "Computer Crossmatch" (Computerized Analysis of the Compatibility between the Donor's Cell Type and the Recipient's Serum or Plasma Type); :  Guidance for Industry. Issue date: April 01, 2011. Get complete insights and analysis.

---

## Details

- Title: "Computer Crossmatch" (Computerized Analysis of the Compatibility between the Donor's Cell Type and the Recipient's Serum or Plasma Type); :  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2011-04-01
- Last Changed: 2019-05-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2007-D-0019">FDA-2007-D-0019</a>

## Related Documents

- [Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-considerations-for-therapeutic-cancer-vaccines-guidance-for-industry/e0e6e4e0-a883-4f71-bf37-784e147d32d9)
- [Preclinical Assessment of Investigational Cellular and Gene Therapy Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/preclinical-assessment-of-investigational-cellular-and-gene-therapy-products-guidance-for-industry/e4aedc4e-81e3-4d2e-b655-2460ccf3a04e)
- [Potency Tests for Cellular and Gene Therapy Products:  Final Guidance for Industry:](https://www.globalkeysolutions.net/guidances/guidance-document/potency-tests-for-cellular-and-gene-therapy-products-final-guidance-for-industry/59c72aad-aad2-413a-82eb-440ea6bc25f8)